NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Philip Newsome
University of Birmingham - Birmingham / United Kingdom
Others
AD Scientific Index ID: 4321602
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Philip Newsome's MOST POPULAR ARTICLES
1-)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementM Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ...Journal of hepatology 73 (1), 202-209, 202015382020
2-)
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver diseaseM Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...Gastroenterology 158 (7), 1999-2014. e1, 202014252020
3-)
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ...Hepatology 78 (6), 1966-1986, 202320792023
4-)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 studyMJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ...The Lancet 387 (10019), 679-690, 201621242016
5-)
A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitisPN Newsome, K Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, ...New England Journal of Medicine 384 (12), 1113-1124, 202114222021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept